• Product nameAnti-Abhd5 antibody
    See all Abhd5 primary antibodies
  • Description
    Goat polyclonal to Abhd5
  • SpecificityThis antibody is not expected to cross-react with ABHD4.
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Mouse, Cow, Human
    Predicted to work with: Rat, Sheep, Dog, Pig, Orangutan
  • Immunogen

    Synthetic peptide:


    , corresponding to internal sequence amino acids 181-192 of Human Abhd5

  • Positive control
    • A431 and NIH-3T3 cell line lysates.



Our Abpromise guarantee covers the use of ab59488 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.2 - 0.6 µg/ml. Detects a band of approximately 40 kDa (predicted molecular weight: 39 kDa). Additional faint bands of 26kDa and 18kDa were observed in NIH-3T3. These bands were successfully blocked by incubation with the immunizing peptide.
ELISA Use at an assay dependent dilution. Peptide ELISA: antibody detection limit dilution 1:8,000.


  • FunctionLysophosphatidic acid acyltransferase which functions in phosphatidic acid biosynthesis. May regulate the cellular storage of triacylglycerol through activation of the phospholipase PNPLA2. Involved in keratinocyte differentiation.
  • Tissue specificityWidely expressed in various tissues, including lymphocytes, liver, skeletal muscle and brain. Expressed by upper epidermal layers and dermal fibroblasts in skin, hepatocytes and neurons (at protein level).
  • Involvement in diseaseDefects in ABHD5 are the cause of Chanarin-Dorfman syndrome (CDS) [MIM:275630]; also called triglyceride storage disease with impaired long-chain fatty acid oxidation or neutral lipid storage disease with ichthyosis. CDS is an autosomal recessive inborn error of lipid metabolism with multisystemic accumulation of triglycerides although plasma concentrations are normal. Clinical characteristics are congenital generalized ichthyosis, vacuolated leukocytes, hepatomegaly, myopathy, cataracts, neurosensory hearing loss and developmental delay. The disorder presents at birth with generalized, fine, white scaling of the skin and a variable degree of erythema resembling non-bullous congenital ichthyosiform erythroderma.
  • Sequence similaritiesBelongs to the peptidase S33 family. ABHD4/ABHD5 subfamily.
  • Developmental stageDetected in fetal epidermis from 49 to 135 days estimated gestational age (at protein level).
  • DomainThe HXXXXD motif is essential for acyltransferase activity and may constitute the binding site for the phosphate moiety of the glycerol-3-phosphate.
  • Cellular localizationCytoplasm. Lipid droplet. Colocalized with PLIN and ADRP on the surface of lipid droplets. The localization is dependent upon the metabolic status of the adipocytes and the activity of PKA.
  • Information by UniProt
  • Database links
  • Alternative names
    • 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 antibody
    • ABHD5 antibody
    • ABHD5_HUMAN antibody
    • Abhydrolase domain containing 5 antibody
    • Abhydrolase domain containing protein 5 antibody
    • Abhydrolase domain-containing protein 5 antibody
    • CDS antibody
    • CGI 58 antibody
    • CGI58 antibody
    • CGI58 protein antibody
    • IECN2 antibody
    • Lipid droplet-binding protein CGI-58 antibody
    • MGC8731 antibody
    • NCIE2 antibody
    see all

Anti-Abhd5 antibody images

References for Anti-Abhd5 antibody (ab59488)

This product has been referenced in:
  • Lin YY  et al. KSRP and MicroRNA 145 Are Negative Regulators of Lipolysis in White Adipose Tissue. Mol Cell Biol 34:2339-2349 (2014). Read more (PubMed: 24732799) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab59488.
Please use the links above to contact us or submit feedback about this product.